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Abstract: Parkinson's disease is characterized by progressive degeneration of the dopaminergic (DA) neurons in the substantia nigra
(SN). However, the mechanism underlying DA cell death remains unclear. While apoptotic cell death has been implicated in DA cell
death in Parkinson’s disease, autophagy - a regulated cellular process for degrading intracellular proteins and organelles under stress
- in Parkinson’s disease is not known. Here, we report evidence of autophagy in DA neurons of the SN in a 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson’s disease. Mice were treated with saline or MPTP (40 mg/kg) and sacrificed
after 7 days, and brain tissue samples were processed for immunohistochemistry using a tyrosine hydroxylase (TH) antibody to
reveal the SN area. TH-positive tissues were then processed for transmission electron microscopy and examined for ultrastructural
evidence of autophagy. MPTP treatment induced significant morphological changes that closely resembled the autophagic process.
This autophagic degeneration was observed in ~35% of DA neurons in MPTP mice. We conclude that at the ultrastructural level
MPTP treatment produced a prominent autophagic process in DA neurons. The identification of autophagy in the MPTP model of
Parkinson’s disease may provide an insight into the mechanism of cell protection and may lead to a novel therapeutic strategy in
Parkinson’s disease.
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Introduction
Parkinson’s disease is a neurodegenerative disease
characterized by a progressive loss of the dopaminergic
neurons (DA) in the substantia nigra pars compacta. The
interest in studying cell loss and the mechanism of cell
death is evident from the enormous number of papers
about Parkinson’s disease in the literature. For the most
part, cell death in Parkinson’s disease is defined in terms
of apoptosis. Apoptosis is defined as an active,
physiological cascade of events, characterized by cell
shrinkage due to dehydration, nuclear chromatin
condensation and fragmentation, and membrane
blebbing. Necrosis as the other type of cell death in
Parkinson’s disease is defined as a passive, degenerative
pathway characterized by cell and mitochondrial
swelling, metabolic collapse, flocculation of chromatin,
rupture of the nuclear and cytoplasmic membrane and
dispersal of cell contents (1). The other cell death

pathway (2), autophagy, is not very clear in
neurodegenerative disease.
At present, the most effective experimental model of
Parkinson’s disease is the 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP) treatment of animals. In
1982, a number of young Californian drug-addicts
developed a severe Parkinson’s-like syndrome after
injecting a potent pethidine derivative contaminated with
MPTP (3,4). Exposure to MPTP produced symptoms of
bradykinesia and rigidity almost identical to those of
idiopathic Parkinson’s disease, and in one patient these
were shown to be related to a severe loss of DA neurons
of the substantia nigra (SN) (3).
Morphological assessment of different modes of cell
death, apoptosis, necrosis or autophagic degeneration,
can contribute significantly to understanding this
neuronal loss. Electron microscopy should be considered
the gold standard for cell death observation (5).
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Autophagy is responsible for the degradation of
normal proteins involved in cellular remodeling found
during metamorphosis, aging and differentiation, as well
as for the digestion and removal of abnormal proteins
that would otherwise accumulate following toxin
exposure, cancer or degenerative disease (6,7).
Autophagy is correlated with the formation of
autophagosomes,
autolysosomes,
electron-dense
membranous autophagic vacuoles (with double
membranes), membranous whorls and multivesicular
bodies, as well as the engulfment of entire organelles (i.e.
mitochondria), which can be seen at the ultrastructural
level (8). A number of studies have demonstrated the
presence of autophagy in the brain in Huntington’s
disease (9). Similarly, autophagic degeneration was
observed in Alzheimer’s disease (10). In 1997, in
Parkinson’s disease patients, an ultrastructural
examination revealed characteristics of apoptosis and
autophagic degeneration in melanized neurons of the SN
(11). The results suggest that even at the final stage of
the disease, the dopaminergic neurons are undergoing an
active process of cell death.
Thus, we designed the following study to test the
evidence for autophagy in DA neurons of SN in the MPTP
model of Parkinson’s disease.

Materials and Methods
Drug treatments: Twelve male mice weighing 20-24 g
were divided into 2 groups and treated with a single
injection of saline or MPTP (40 mg/kg) i.p.
Tyrosine hydroxylase (TH) immunostaining: One week
after the treatment, the mice were transcardially
perfused with phosphate-buffered saline (PBS) (pH 7.4)
followed by 4% paraformaldehyde. Brains were serially
sectioned from roughly the beginning to the end of the
SN area, with the help of a mouse brain atlas, on a
cryomicrotome at 40 µm. Free floating sections were
incubated overnight at 4 °C with a monoclonal anti-TH
antibody (1:800) (Sigma) to reveal the SN cells, and
developed with an avidin-biotin-peroxidase method.
Ultrastructural Analysis: For electron microscopy,
after TH staining and identifying the SN area, free
floating sections from the MPTP or saline treated group
were used. Tissue pieces 40 µm thick were first
immersed in 2.5% glutaraldehyde in 0.1 phosphate
buffer (pH 7.2) postfixed in 1% osmium tetroxide in 0.1
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phosphate buffer (pH 7.4) and then dehydrated in graded
ethanol series and flat embedded in Araldite. On the
Araldite block surface, only the TH immunostained area
(SN) was cut, and the other area (unstained) was left out
by trimming. Ultrathin sections (40-60 nm thick) taken at
the level of the brown (immunostained) SN area were
placed on grids (200 mesh) and double stained with
uranyl acetate and lead citrate. The grids containing the
sections were observed under a Carl Zeiss EM-900
electron microscope, and photomicrographs were taken.
Semiquantitative morphological analysis of autophagic
structure: Whole sections on grids from each block of
brain were examined with an electron microscope, and
the total number of cells and the number of cells with an
autophagic structure were analyzed. Autophagic structure
was defined with a double membrane as described before
(8). The percentages of cells with an autophagic structure
were calculated in the total number of neurons from the
SN area. The difference between the groups was
examined by Student’s t test, and P values less than 0.05
were considered significant.

Results
MPTP induced a loss of DA in the SN (Figure 1). At
the ultrastructural level, MPTP treatment induced
significant morphological changes, which closely
resembled the autophagic process, and C-shaped
multivesicular bodies (Figure 2). The percentage of cells
with an autophagic structure was ~35% of the total
number of neurons from the SN area. In autophagic
degenerating neuron cytoplasm, a double membrane
structure with lysosome–like vacuoles was observed.
Numerous vacuoles containing cytoplasmic fragments
were present in the cytoplasm. The number of vacuoles
containing materials was very high in the DA neurons of
MPTP-treated mice. Features of autophagy were
occasionally observed in < 3% of DA neurons of salinetreated mice. The difference between the groups was
significant (p < 0.05).

Discussion
In the present study, we observed autophagic vacuoles
in the SN neurons of MPTP-treated mice. Autophagy may
utilize some common regulatory mechanism in these cells.
Furthermore, the onset of autophagy can precede that of
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Figure 1. MPTP-induced loss of dopaminergic neurons in substantia nigra. Dopaminergic cells stained with antibodies for tyrosine hydroxylase in the
substantia nigra of MPTP and saline treated mice 7 days after treatment. The number of neurons is less in the MPTP treated group than in
control. SNc: Substantia Nigra compacta (x50).

Figure 2. Electron microscopic photomicrographs showing autophagic structures and C-shaped multivesicular bodies (arrows) in MPTP treated
dopaminergic neurons. N: nucleus. Tissue samples were taken from the MPTP and saline treated groups (x5000).
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apoptosis and, according to at least one report, delays
apoptosis (12,13). In newborn rat hepatocytes, the
inhibition of cyclic AMP produces glycogen autophagy
(14). It has been strongly suggested that MPTP
administration produces a cyclic AMP decrease in SN cells
(15). Under nutrient-deficient conditions, the yeast S.
cerevisiae sequesters its own cytoplasmic components
into vacuoles in the form of “autophagic bodies”, and
spherical structures completely enclosed in a double
membrane were found near the vacuoles of proteasedeficient mutant cells when the cells were shifted to
nutrient-starvation media (5). In addition, the induction
of increased intracellular levels of lysosomal proteinases
and their mRNA by treatment with a combination of
hormones showed C-shaped multivesicular bodies and the
formation of autophagic vacuoles (16).
Autophagy may be a degrading process for
intracellular proteins via ubiquitin-mediated pathways
(17). It can be speculated that Lewy bodies in
neurodegenerative diseases may be produced by the
autophagic process (18). Nowadays, intracellular protein
accumulations in neurodegenerative diseases are
becoming very important (19-21). The relation between
intracellular protein accumulations and the autophagic
process needs to be studied further.

SN (22). Based on this report, we suggest that a defense
or protective mechanism can be seen after the injection of
MPTP, because the cells observed on the seventh day
were alive with an autophagic structure.
Our data showed that autophagy was stimulated by
MPTP treatment. Autophagy may reduce the toxic effect
of MPTP on neuronal cells in SN. The blockade of TH+
cell death may be related to the blockade of the cell death
pathway by producing autophagic granules. The
mechanisms of autophagy in the cell death pathway are
unclear. If there is any relation between the blockade of
cell death and autophagy, we may speculate that
autophagic structures play a role in blocking the cell death
pathway. If so, it can be also speculated that defects in
autophagy have serious consequences, and that these can
be linked to neurodegenerative disease. In addition, it
may be of some value in the treatment of Parkinson’s
disease or in reducing the risk of neurodegeneration.
These results raise the possibility that the existing
autophagy in neurons in the MPTP model of Parkinson’s
disease may provide an important clue as to the
neurodegenerative mechanism. The possibility of
producing an autophagic structure may protect the cells,
and defects or insufficiencies in this process may lead the
cells to die in neurodegenerative diseases.

A time course study of DA neuronal death caused by
MPTP showed that the active phase of degeneration
began at 12 h postinjection and continued for up to 4
days. During this period, there was a greater decrease in
TH-defined neurons than in Nissl-stained neurons,
suggesting that MPTP can cause a loss in TH without
necessarily destroying the neuron. Cell death occurs in 24 days after MPTP treatment, and, at the seventh day
postinjection, TH immunostaining can be used to
accurately determine the number of living neurons in the
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